Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
Hong Kong
· Delayed Price · Currency is HKD 5.80
-0.08 (-1.36%)
Jan 30, 2026, 3:55 PM HKT
Charmacy Pharmaceutical Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 29, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 626 | 1,058 | 1,400 | 744 | 603 | 588 | Upgrade
|
| Market Cap Growth | -24.18% | -24.38% | 88.10% | 23.48% | 2.57% | -26.88% | Upgrade
|
| Enterprise Value | 1,376 | 1,681 | 1,659 | 1,548 | 1,675 | 1,021 | Upgrade
|
| Last Close Price | 5.80 | 9.18 | 11.85 | 5.92 | 4.79 | 4.48 | Upgrade
|
| PE Ratio | 11.84 | 18.67 | 24.75 | 7.28 | 21.21 | 12.20 | Upgrade
|
| Forward PE | - | 13.45 | 13.45 | 13.45 | 13.45 | 13.45 | Upgrade
|
| PS Ratio | 0.13 | 0.22 | 0.29 | 0.16 | 0.13 | 0.12 | Upgrade
|
| PB Ratio | 0.97 | 1.61 | 2.13 | 1.11 | 0.97 | 0.98 | Upgrade
|
| P/TBV Ratio | 1.11 | 1.84 | 2.47 | 1.30 | 1.38 | 1.44 | Upgrade
|
| P/FCF Ratio | 2.32 | 11.01 | - | 18.56 | - | 6.26 | Upgrade
|
| P/OCF Ratio | 2.23 | 9.38 | - | 14.94 | - | 3.77 | Upgrade
|
| EV/Sales Ratio | 0.30 | 0.36 | 0.34 | 0.33 | 0.36 | 0.22 | Upgrade
|
| EV/EBITDA Ratio | 7.83 | 10.15 | 11.59 | 11.32 | 13.18 | 7.83 | Upgrade
|
| EV/EBIT Ratio | 9.58 | 11.69 | 13.91 | 14.65 | 18.33 | 9.76 | Upgrade
|
| EV/FCF Ratio | 5.09 | 17.50 | - | 38.62 | - | 10.87 | Upgrade
|
| Debt / Equity Ratio | 2.04 | 2.28 | 2.30 | 1.99 | 2.63 | 2.50 | Upgrade
|
| Debt / EBITDA Ratio | 7.52 | 8.54 | 10.20 | 9.55 | 12.47 | 11.14 | Upgrade
|
| Debt / FCF Ratio | 4.89 | 15.61 | - | 33.43 | - | 15.86 | Upgrade
|
| Net Debt / Equity Ratio | 1.16 | 1.35 | 1.22 | 1.15 | 1.36 | 1.30 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.55 | 5.37 | 5.62 | 5.63 | 6.62 | 5.94 | Upgrade
|
| Net Debt / FCF Ratio | 2.77 | 9.25 | -5.31 | 19.22 | -15.37 | 8.25 | Upgrade
|
| Asset Turnover | 1.25 | 1.32 | 1.44 | 1.48 | 1.36 | 1.51 | Upgrade
|
| Inventory Turnover | 5.17 | 5.75 | 6.04 | 7.13 | 6.51 | 6.83 | Upgrade
|
| Quick Ratio | 0.64 | 0.66 | 0.63 | 0.66 | 0.66 | 0.65 | Upgrade
|
| Current Ratio | 1.09 | 1.09 | 1.07 | 1.09 | 1.04 | 1.04 | Upgrade
|
| Return on Equity (ROE) | 8.15% | 8.76% | 8.61% | 16.46% | 4.60% | 8.22% | Upgrade
|
| Return on Assets (ROA) | 2.42% | 2.52% | 2.21% | 2.08% | 1.67% | 2.08% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.64% | 7.27% | 6.33% | 5.62% | 4.46% | 5.86% | Upgrade
|
| Return on Capital Employed (ROCE) | 19.70% | 20.20% | 17.20% | 15.30% | 12.30% | 13.80% | Upgrade
|
| Earnings Yield | 8.45% | 5.36% | 4.04% | 13.74% | 4.72% | 8.20% | Upgrade
|
| FCF Yield | 43.17% | 9.08% | -10.81% | 5.39% | -9.08% | 15.99% | Upgrade
|
| Dividend Yield | 8.43% | 5.22% | 2.79% | 8.60% | - | 5.30% | Upgrade
|
| Payout Ratio | 135.85% | 120.49% | 147.05% | 31.44% | 226.73% | 139.34% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | 0.01% | -0.00% | -0.01% | 0.01% | -0.01% | Upgrade
|
| Total Shareholder Return | 8.43% | 5.23% | 2.79% | 8.59% | 0.01% | 5.29% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.